Composed of experts from academia and industry, the SSAB will closely work with Biofortis’ management team. The SSAB’ missions will be to analyze the current scientific paradigm in the microbiome science, drive and enhance surveillance for partnership & collaborations, predict both macro and microeconomic evolutions of the microbiome market and contribute to the development of Biofortis’ strategy and to the evolution of its services in clinical studies and microbiota.
Internal members
Benoit Fouchaq
President
Sébastien Leuillet
CTO and Head of Biometrics & Data Science BU
External members
Murielle Cazaubiel
Chief Medical Officer of VALBIOTIS
Etienne Casal
Consultant
Jeroen Raes
Associate Professor in Microbiota Bioinformatics & Systems Biology at KU Leuven and VIB group leader
Isabelle De Crémoux
CEO of Seventure Partners
Hervé Affagard
CEO of MaaT Pharma